Most studies of parathyroid hormone have been with hormone of bovine origin. The amino acid sequence (Fig 1) of this has recently been determined (Niall et al. 1970 , Brewer & Ronan 1970 . The amino terminal sequence of the first 34 residues has been synthesized (Potts et al. 1971 ). This synthetic peptide has been shown to be biologically active and to react with antisera produced against the native hormone. Human parathyroid hormone has been shown immunologically to differ from bovine parathyroid (O'Riordan et al. 1969) . Though the human hormone has only been isolated in microgram quantities, its amino acid composition has been shown to differ from that of bovine parathyroid hormone, especially by containing three residues of threonine which is absent from the bovine hormone (O'Riordan et al. 1971) .
Recently, porcine parathyroid hormone has been isolated (Woodhead et al. 1971 ) and has been shown to differ immunologically both from bovine and from human parathyroid hormones (Woodhead & O'Riordan 1971) . These differences were shown in a radioimmunoassay system with antisera against bovine parathyroid hormone and 125I-labelled bovine parathyroid hormone. When labelled porcine parathyroid hormone instead was used in this system the hormone from the three species behaved similarly. It seems likely that with labelled porcine parathyroid hormone, the behaviour of immunologically active similar parts of the molecules is being monitored and that with labelled bovine hormone and antisera against bovine parathyroid hormone, the behaviour of parts of the molecules that differ is being monitored.
The amino acid composition of porcine parathyroid hormone differs from bovine parathyroid hormone in five respects. There is one fewer residue of aspartic acid, of alanine, and of phenyl alanine. There is one (rather than two 2 3 4 5 6 7 8 9 10 1 12 13 14 H2NA G (Niallet al. 1970 , Brewer et al. 1970 1264 Proc. roy. Soc. Med. Volume 64 December 1971 50 residues) of methionine and no tyrosine. In place of these deletions there are insertions of a valine, a glycine and a histidine and insertion of two residues of leucine. These five differences in composition mean that there must be at least five differences in sequence. As shown in Fig 2, we have determined the sequence of residues 1-62 and identified the composition of residue 74. For this, sequential Edman degradation with formation of phenyl thiohydantoin derivatives was used for residues 1-58: these residues were then identified by gas chromatography and thin-layer chromatography. The composition of positions 53-61 and of position 74 was obtained by similar analysis of a peptide containing residues 53-84. This peptide was isolated after tryptic digestion ofporcine hormone that had been treated with maleic anhydride to reduce the number of cleavage products. In addition to the five differences attributable to differences in composition, there are differences due to internal rearrangement; these arise because the amino terminal alanine residue of bovine parathyroid hormone is replaced by a serine residue in the porcine hormone. The composition of residues 62-73 and 75-84 is being examined carefully to be certain that there are no further internal rearrangements, and the full sequence should be known shortly1. Each of the differences shown so far between porcine and bovine parathyroid hormones can be attributed to single base shifts, i.e. to single mutations, seven in all.
There is substitution of histidine for tyrosine at position 43. This substitution would alter the charge properties of the molecule at this point. The lack of tyrosine was surprising, since before this had been found we had labelled porcine parathyroid hormone with 1"I. Presumably one of the histidines is being iodinated. The lack of tyrosine is also interesting because it did seem in bovine parathyroid hormone that the tyrosine was essential for biological and immunological activity, since tyrosinase treatment inactivates the bovine parathyroid hormone (Potts et al. 1966) . It would appear that while modification of the tyrosine residue does affect activity, replacement of it does not.
From the point of view of structure-function relationships, the presence of only one methionine in porcine parathyroid is particularly interesting. Bovine parathyroid hormone contains two methionine residues (at position 8 and 18). Mild oxidation of these destroys biological activity but does not affect immunological activity. It is not known whether one of these 'Added in proof (October 1971): Subsequently we have shown that the sequence of the rest of the molecule is the same in porcine as in bovine parathyroid hormone 1 2 3 4 5 6 7 8 9 10 11 12 13 14 two methionine residues is particularly important. In porcine parathyroid hormone, we have found that oxidation of the single methionine at position 8 destroys biological activity but again this does not affect immunological activity. Since replacement of the methionine residue at position 18 by leucine does not affect biological activity, it will be interesting to examine the properties of a synthetic peptide, which is now being prepared, in which both the methionine residues have been replaced. It is hoped that soon more human parathyroid hormone will be isolated so that its sequence too can be determined, thus opening the way to further structure-function analyses and, of course, synthesis of human parathyroid hormone. The precise clinical diagnosis of hypogonadism in the male may be difficult. Thus, patients with isolated gonadotrophin deficiency may present witb gyn=comastia and small testes and be clinically indistinguishable from those with Klinefelter's syndrome. Measurements of levels of serum luteIniing hormone (LH) and plasma testosterone-like substances (TLS) have been applied to the investigation of various forms of hypogonadism.
Methods and Results LH was measured by a double antibody radioimmunoassay; MRC Research Standard A human pituitary ICSH/LH (63/15) was used as standard. Owing to doubt as to the exact content of each ampoule by bioassay, one ampoule was defined as containing 10 units. In our assay system 1 such unit is equivalent to 8-4 i.u. of 2nd IRP HMG. Plasma TLS was measured by competitive protein binding (Anderson 1970) . This system measures testosterone and closely related androgens such as dihydrotestosterone, recently shown to be present in human plasma (Ito & Horton 1970 , Tremblay et al. 1970 .
Basal measurements of LH have been found to distinguish reliably between gonadotrophin deficiency and chromatin-positive Klinefelter's 'Present address: Department of Medicine, St Bartholomew's Hospital, London ECi syndrome (Fig 1) . Thus, most subjects with panhypopituitarism or isolated gonadotrophin deficiency have LH levels that are below normal, whereas levels are elevated in all 8 men with untreated Klinefelter's syndrome. TLS levels are lowest in those with panhypopituitarism and below normal in men with isolated gonadotrophin deficiency. Greater variation in TLS is seen in Klinefelter's syndrome, levels overlapping with the normal range; this is in keeping with the variable, degree of masculinization seen in this syndrome.
These measurements have also been used as the basis for two stimulation tests, to be described in greater detail elsewhere.
A standard stimulation test of Leydig cell reserve has been developed, using two intramuscular injections of human chorionic gonadotrophin (HCG) 2,000 i.u. three days apart. Normal men (15) showed a peak TLS response 24-72 hours after the first injection (mean increase 110%, range 55-166%). There was no consistent additional response to the second injection.
Three adult men with panhypopituitarism of recent onset showed a rapid and progressive TLS response to HCG, mean levels rising from 19 to 151 ng/ml. The response was more variable in isolated gonadotrophin deficiency, and mean levels (9 subjects) rose from 2-6 to 8&4 ng/ml. All of 6 men with Klinefelter's syndrome also responded to HCG, mean levels rising from 5-4 to 12-1 ng/ml.
In the second test clomiphene citrate has been used to assess pituitary LH reserve. In normal subjects given doses of 3 mg/kg/day (maximum 200 mg) for 10 days, LH and TLS levels rose progressively, mean levels doubling (Marshall et al. 1970) . No response was seen in patients with panhypopituitarism or isolated gonadotrophin deficiency, levels remainng low. In 
